Pfizer to cut around 2 percent of jobs through early next year
NEW YORK (Reuters) - U.S. drugmaker Pfizer Inc (PFE.N) plans to reduce its global headcount by around 2 percent through voluntary retirements and layoffs this year and early next year, as it looks to streamline its corporate structure and eliminate some managerial roles and responsibilities.
Pfizer has around 90,000 employees worldwide.
Pfizer spokeswoman Sally Beatty said the job cuts were “about creating a simpler, more efficient structure and not achieving cost savings.”
The job cuts were originally reported by CNBC.
The move follows the announcement earlier this month that Chief Operating Officer Albert Bourla would succeed Ian Read as chief executive in January. The company also added new responsibilities for many of its top managers and hired a new chief digital officer.
Shares of Pfizer were up 1.8 percent at $44.70 in early afternoon trading on the New York Stock Exchange. Its shares are up around 20 percent this year, outperforming the Standard & Poors 500 index, which is up about 4 percent over the same period.
Reporting by Michael Erman; Editing by Bill Berkrot
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.  |